- In patients at risk for gastric cancer, administration of Helicobacter pylori resulted in a 50% reduction in tumor development. This is the result of a 470 patient randomized, placebo-controlled trial. http://www.nejm.org/doi/full/10.1056/nejmoa1708423?query=featured_home 5 comments science
Linked pages
Related searches:
Search whole site: site:www.nejm.org
Search title: Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer | NEJM
See how to search.